Barclays upgraded shares of Recordati Industria Chimica e Farmaceutica (OTCMKTS:RCDTF – Free Report) to a strong sell rating in a research note published on Tuesday, Zacks.com reports.
Separately, Royal Bank of Canada raised Recordati Industria Chimica e Farmaceutica to a “hold” rating in a report on Monday, October 7th.
Check Out Our Latest Report on Recordati Industria Chimica e Farmaceutica
Recordati Industria Chimica e Farmaceutica Stock Performance
Recordati Industria Chimica e Farmaceutica (OTCMKTS:RCDTF – Get Free Report) last posted its earnings results on Tuesday, July 30th. The company reported $0.70 EPS for the quarter. The company had revenue of $622.00 million during the quarter. Recordati Industria Chimica e Farmaceutica had a return on equity of 30.78% and a net margin of 17.41%.
About Recordati Industria Chimica e Farmaceutica
Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, and marketing of pharmaceuticals worldwide. The company operates through Specialty and Primary Care and Rare Diseases segments. Its product pipeline includes REC 0559 which is in Phase II for the treatment of Neurotrophic Keratitis; REC 0545 for acute decompensation in maple syrup urine diseases; ISTURISA for endogenous Cushing's syndrome; and CYSTADROPS, an corneal cystine deposits in patients with cystinosis.
Further Reading
- Five stocks we like better than Recordati Industria Chimica e Farmaceutica
- 3 Fintech Stocks With Good 2021 Prospects
- Why Meta’s Pre-Earnings Dip Could Be A Golden Entry Opportunity
- Want to Profit on the Downtrend? Downtrends, Explained.
- Spirit Airlines Stock Nearly Doubled: Are Clear Skies Ahead?
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Tesla Stock: Buy the Dips, Sell the Rips
Receive News & Ratings for Recordati Industria Chimica e Farmaceutica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Recordati Industria Chimica e Farmaceutica and related companies with MarketBeat.com's FREE daily email newsletter.